Published in Anal Chem on March 15, 2006
Negative electron transfer dissociation of glycosaminoglycans. Anal Chem (2010) 1.39
Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. Anal Chem (2012) 1.26
On-line separations combined with MS for analysis of glycosaminoglycans. Mass Spectrom Rev (2009) 1.19
Enzymatic synthesis of glycosaminoglycan heparin. Semin Thromb Hemost (2007) 1.00
Proteoglycan sequence. Mol Biosyst (2012) 0.98
Hyphenated techniques for the analysis of heparin and heparan sulfate. Anal Bioanal Chem (2010) 0.95
LC-MS(n) analysis of isomeric chondroitin sulfate oligosaccharides using a chemical derivatization strategy. J Am Soc Mass Spectrom (2011) 0.94
Hexuronic acid stereochemistry determination in chondroitin sulfate glycosaminoglycan oligosaccharides by electron detachment dissociation. J Am Soc Mass Spectrom (2012) 0.93
Ionic liquid matrix for direct UV-MALDI-TOF-MS analysis of dermatan sulfate and chondroitin sulfate oligosaccharides. Anal Chem (2007) 0.90
Harnessing glycomics technologies: integrating structure with function for glycan characterization. Electrophoresis (2012) 0.89
Improved matrix-assisted laser desorption/ionization mass spectrometric detection of glycosaminoglycan disaccharides as cesium salts. Rapid Commun Mass Spectrom (2007) 0.86
Applications of mass spectrometry to structural analysis of marine oligosaccharides. Mar Drugs (2014) 0.82
Electron capture dissociation, electron detachment dissociation and infrared multiphoton dissociation of sucrose octasulfate. Eur J Mass Spectrom (Chichester, Eng) (2009) 0.81
Recent advances in sialic acid-focused glycomics. J Proteomics (2012) 0.78
New methods to study the composition and structure of the extracellular matrix in natural and bioengineered tissues. Biomatter (2013) 0.78
Analysis of Glycosaminoglycans Using Mass Spectrometry. Curr Proteomics (2015) 0.76
MALDI Matrix Research for Biopolymers. Mass Spectrom (Tokyo) (2015) 0.75
Heparin-protein interactions. Angew Chem Int Ed Engl (2002) 7.27
Mass spectrometry of oligosaccharides. Mass Spectrom Rev (2004) 2.38
Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom Rev (2000) 1.87
Sequencing complex polysaccharides. Science (1999) 1.85
Order out of complexity--protein structures that interact with heparin. Curr Opin Struct Biol (2001) 1.45
The desorption process in MALDI. Chem Rev (2003) 1.43
MALDI ionization: the role of in-plume processes. Chem Rev (2003) 1.36
Utility of non-covalent complexes in the matrix-assisted laser desorption ionization mass spectrometry of heparin-derived oligosaccharides. Carbohydr Res (1995) 1.29
Mass spectrometric molecular-weight determination of highly acidic compounds of biological significance via their complexes with basic polypeptides. Proc Natl Acad Sci U S A (1994) 1.26
Analysis of acidic oligosaccharides and glycopeptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem (1996) 1.23
Ionic liquids as matrixes for matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (2001) 1.15
Characterizing ionic liquids on the basis of multiple solvation interactions. J Am Chem Soc (2002) 1.14
Examination of ionic liquids and their interaction with molecules, when used as stationary phases in gas chromatography. Anal Chem (1999) 1.10
Carbohydrates as the next frontier in pharmaceutical research. Chemistry (2005) 1.05
Secondary ion-molecule reactions in matrix-assisted laser desorption/ionization J Mass Spectrom (2000) 1.00
Ionic-liquid matrices for improved analysis of phospholipids by MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom (2005) 0.98
Evaluation of counterions for electrospray ionization mass spectral analysis of a highly sulfated carbohydrate, sucrose octasulfate. Anal Chem (2003) 0.96
Internal energy build-up in matrix-assisted laser desorption/ionization. J Mass Spectrom (2004) 0.96
2,5-Dihydroxybenzoic acid butylamine and other ionic liquid matrixes for enhanced MALDI-MS analysis of biomolecules. Anal Chem (2004) 0.95
Ionic-liquid matrices for quantitative analysis by MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom (2004) 0.94
Ionic matrices for matrix-assisted laser desorption/ionization time-of-flight detection of DNA oligomers. Rapid Commun Mass Spectrom (2003) 0.84
Sodium-tolerant matrix for matrix-assisted laser desorption/ionization mass spectrometry and post-source decay of oligonucleotides. Rapid Commun Mass Spectrom (2002) 0.82
Internal energies of analyte ions generated from different matrix-assisted laser desorption/ionization matrices J Mass Spectrom (2000) 0.81
Heparin-protein interactions. Angew Chem Int Ed Engl (2002) 7.27
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol (2007) 3.73
Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem (2003) 2.94
Lessons learned from the contamination of heparin. Nat Prod Rep (2009) 2.81
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science (2011) 2.79
Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology (2005) 2.46
The proteoglycan bikunin has a defined sequence. Nat Chem Biol (2011) 2.14
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev (2005) 2.10
The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol (2009) 2.06
Solution structures of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc (2008) 2.02
Flexible energy storage devices based on nanocomposite paper. Proc Natl Acad Sci U S A (2007) 2.02
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet (2004) 1.92
Electron detachment dissociation of glycosaminoglycan tetrasaccharides. J Am Soc Mass Spectrom (2006) 1.89
Enzymatic redesigning of biologically active heparan sulfate. J Biol Chem (2005) 1.89
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol (2006) 1.71
Heparin-binding domains in vascular biology. Arterioscler Thromb Vasc Biol (2004) 1.71
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc Natl Acad Sci U S A (2004) 1.70
Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet (2003) 1.66
E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol Bioeng (2010) 1.65
Chemoenzymatic design of heparan sulfate oligosaccharides. J Biol Chem (2010) 1.64
Distinguishing glucuronic from iduronic acid in glycosaminoglycan tetrasaccharides by using electron detachment dissociation. Anal Chem (2007) 1.61
Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D. J Biol Chem (2002) 1.53
Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides. J Biol Chem (2003) 1.51
Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J Proteome Res (2007) 1.46
Ionic liquid-mediated selective extraction of lignin from wood leading to enhanced enzymatic cellulose hydrolysis. Biotechnol Bioeng (2009) 1.46
Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry. Anal Chem (2009) 1.45
Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J Biol Chem (2004) 1.42
Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry. J Chromatogr A (2011) 1.42
Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1. J Biol Chem (2004) 1.41
Electron detachment dissociation of dermatan sulfate oligosaccharides. J Am Soc Mass Spectrom (2007) 1.40
Influence of charge state and sodium cationization on the electron detachment dissociation and infrared multiphoton dissociation of glycosaminoglycan oligosaccharides. J Am Soc Mass Spectrom (2008) 1.40
Negative electron transfer dissociation of glycosaminoglycans. Anal Chem (2010) 1.39
Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J Biol Chem (2004) 1.38
Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem (2008) 1.38
Structural analysis of bikunin glycosaminoglycan. J Am Chem Soc (2008) 1.37
Orthogonal analytical approaches to detect potential contaminants in heparin. Proc Natl Acad Sci U S A (2009) 1.36
Control of the heparosan N-deacetylation leads to an improved bioengineered heparin. Appl Microbiol Biotechnol (2011) 1.33
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry (2004) 1.33
Heparin accelerates gelsolin amyloidogenesis. Biochemistry (2006) 1.31
Room temperature ionic liquids as emerging solvents for the pretreatment of lignocellulosic biomass. Biotechnol Bioeng (2011) 1.31
Analysis of E. coli K5 capsular polysaccharide heparosan. Anal Bioanal Chem (2010) 1.30
Enzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin-protein interactions. Biochem Biophys Res Commun (2005) 1.29
Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal Biochem (2011) 1.28
Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column. Anal Biochem (2006) 1.27
Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. Anal Chem (2012) 1.26
Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides. Curr Med Chem (2003) 1.25
Proteoglycomics: recent progress and future challenges. OMICS (2010) 1.25
Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin. J Med Chem (2010) 1.24
Electron-induced dissociation of glycosaminoglycan tetrasaccharides. J Am Soc Mass Spectrom (2008) 1.23
The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery. J Biol Chem (2004) 1.23
Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta (2005) 1.22
Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry (2008) 1.21
Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively. Carbohydr Res (2002) 1.20
Preparation of biopolymer fibers by electrospinning from room temperature ionic liquids. Biomacromolecules (2006) 1.19
Engineering of routes to heparin and related polysaccharides. Appl Microbiol Biotechnol (2011) 1.19
Structural characterization of human liver heparan sulfate. Biochim Biophys Acta (2004) 1.18
Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE. J Pharm Sci (2009) 1.16
Isolation and characterization of heparan sulfate from various murine tissues. Glycoconj J (2006) 1.15
Immobilization of heparin: approaches and applications. Curr Top Med Chem (2008) 1.14
High-resolution crystal structure of Arthrobacter aurescens chondroitin AC lyase: an enzyme-substrate complex defines the catalytic mechanism. J Mol Biol (2004) 1.14
Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Mol Cell Biol (2005) 1.13
Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities. Biomacromolecules (2009) 1.12
Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins. Biochem Pharmacol (2009) 1.12
Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin. Proc Natl Acad Sci U S A (2012) 1.11
Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate. Am J Respir Cell Mol Biol (2009) 1.11
Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages. Glycobiology (2010) 1.11
Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. J Med Chem (2008) 1.11
Ultraperformance liquid chromatography with electrospray ionization ion trap mass spectrometry for chondroitin disaccharide analysis. Anal Biochem (2009) 1.10
Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation. Anal Chem (2012) 1.10
Kinetic and structural studies on interactions between heparin or heparan sulfate and proteins of the hedgehog signaling pathway. Biochemistry (2007) 1.10
Recent progress and applications in glycosaminoglycan and heparin research. Curr Opin Chem Biol (2009) 1.10
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Cancer Res (2011) 1.09
Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes. Biochemistry (2009) 1.09
Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin. Metab Eng (2012) 1.09
Structural characterization of pharmaceutical heparins prepared from different animal tissues. J Pharm Sci (2013) 1.08
Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties. Nanotechnology (2009) 1.08
Structural characterization of glycosaminoglycans from zebrafish in different ages. Glycoconj J (2008) 1.08
Structural characterization of heparins from different commercial sources. Anal Bioanal Chem (2011) 1.07
Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett (2007) 1.07
High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan-derived oligosaccharides. Nat Protoc (2010) 1.07
Separation of a complex mixture of heparin-derived oligosaccharides using reversed-phase high-performance liquid chromatography. J Chromatogr A (2003) 1.06
High-resolution preparative separation of glycosaminoglycan oligosaccharides by polyacrylamide gel electrophoresis. Anal Biochem (2010) 1.06
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol Rev (2014) 1.05
Mosquito heparan sulfate and its potential role in malaria infection and transmission. J Biol Chem (2007) 1.05
Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site. Carbohydr Res (2002) 1.05
Toward an artificial Golgi: redesigning the biological activities of heparan sulfate on a digital microfluidic chip. J Am Chem Soc (2009) 1.04
Glycosaminoglycans in infectious disease. Biol Rev Camb Philos Soc (2013) 1.04
Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: implications for mechanisms of action and resistance. Malar J (2009) 1.03
Chemoenzymatic synthesis of heparan sulfate and heparin. Nat Prod Rep (2014) 1.03
Tandem MS can distinguish hyaluronic acid from N-acetylheparosan. J Am Soc Mass Spectrom (2007) 1.02
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations. Anal Biochem (2009) 1.02
Blood compatible carbon nanotubes--nano-based neoproteoglycans. Langmuir (2006) 1.02